Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.97 +0.45 (+1.52%)
As of: Sep 30, 2026 · 2:16 PM EDT

Lakefront Biotherapeutics (LKFT) Receivables - Other (2018 - 2019)

Updated

Lakefront Biotherapeutics' Receivables - Other was $6.51 billion in the quarter ended Sep 30, 2019, up 276.8% from $1.73 billion a year earlier.

Analysis

Lakefront Biotherapeutics (LKFT) Receivables - Other (2018 - 2019) Analysis & Trends

As of Dec 31, 2018, Receivables - Other at Lakefront Biotherapeutics came in at $1.7 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 6.51 Bn
Dec 31, 2018 1.64 Bn
Sep 30, 2018 1.73 Bn
API Access

Lakefront Biotherapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=LKFT&period=max&api_key=YOUR_API_KEY